Riskpilot← Back to searchSign inGet full accessMatangen AB
ABActiveOrg 5569511552Västra Parkgatan 12 Lgh 1001Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2025
SEK 621K
-31% vs 2024
EBITDA margin
50.4%
-40% vs 2024
Equity ratio
78.2%
Financial strength
Net profit 2025
SEK 281K
-24% vs 2024
| Revenue | SEK 621K | -31% |
| EBITDA | SEK 313K | -40% |
| Net profit | SEK 281K | -24% |
| Total assets | SEK 2M | -3% |
| Equity | SEK 1,6M | -1% |
| Employees | 0 | — |
Legal name
Matangen AB
Org number
5569511552
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 november 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bokföring. Handel med värdepapper. Handel med fastigheter. Produktion av utbildning för hälso och sjukvård. Utbildning.
Address
Västra Parkgatan 12 Lgh 1001
Email
matsangerud@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 685 | 898 | 621 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −10 | −8 | 403 | 522 | 313 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −10 | −8 | 403 | 522 | 313 |
| Net financials | — | — | 4 | 4 | 1 |
| Profit before tax | 70 | 111 | 308 | 470 | 359 |
| Tax | −16 | −25 | −64 | −100 | −77 |
| Net profit | 54 | 86 | 244 | 370 | 281 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 509 | 1 376 | 1 620 | 2 046 | 1 983 |
| Equity | 1 070 | 1 056 | 1 200 | 1 570 | 1 551 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 6 | 6 | 6 | 6 | 6 |
| Total debt | 6 | 6 | 6 | 6 | 6 |
EBITDA margin
50.4%
This company
15.8%
Market median
+219% vs market
20212025
Equity ratio
78.2%
This company
38.2%
Market median
+105% vs market
20212025
Return on equity
18.1%
This company
18.4%
Market median
+2% vs market
20212025
Net profit margin
45.3%
This company
8.1%
Market median
+459% vs market
20212025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20212025
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AI Chief Executive Officer | Chief Executive Officer | 2022 |
GM Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Matangen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ingeborg Angerud | Chief Executive Officer | 0 companies |
| Gudrun Maria Angerud | Chief Executive Officer | 0 companies |
| Tilda Anna Maria Angerud | Board of Directors | 0 companies |
| Mats Roger Angerud | Chairman | 0 companies |